Postgrad Med J

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Talwar, S
Right arrow Articles by Haywood, G A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Talwar, S
Right arrow Articles by Haywood, G A
Postgraduate Medical Journal 2005;81:459-462
© 2005 Fellowship of Postgraduate Medicine


ORIGINAL ARTICLE

Disease progression and adverse events in patients listed for elective percutaneous coronary intervention

S Talwar , M Karpha , R Thomas , C Vurwerk , I C Cox , C J Burrell , J G Motwani , T J Gilbert , G A Haywood

South West Cardiothoracic Centre, Derriford Hospital, Plymouth, UK

Correspondence to:
Correspondence to:
Dr G A Haywood
South West Cardiothoracic Centre, Derriford Hospital, Plymouth, PL6 8DH, UK; guy.haywood{at}phnt.swest.nhs.uk

Objective: To record disease progression and the timing of adverse events in patients on a waiting list for elective percutaneous coronary intervention (PCI).

Design: Observational prospective study.

Settings: A UK tertiary cardiothoracic centre, at a time when waiting lists for PCI were up to 18 months.

Patients: 145 patients (116 men, median age 59.5 years) placed on an elective waiting list for PCI between October 1998 and September 1999.

Main outcome measures: Adverse events recorded were death, myocardial infarction, need for urgent hospital admission because of unstable angina, and need for emergency revascularisation while waiting for PCI.

Results: During a median follow up of 10 months (range 1–18 months), nine (6.2%) patients experienced an adverse event. Eight (5.52%) patients were admitted with unstable angina as emergencies. One was admitted with a myocardial infarction. Twenty nine (20.0%) patients had significant disease progression at the time of the repeat angiogram before PCI. In 10 (7%), disease had progressed so that PCI was no longer feasible and patients were referred for coronary artery bypass graft. Sixteen (11%) were removed from the PCI waiting list because of almost complete resolution of their anginal symptoms.

Conclusion: Adverse coronary events and clinically significant disease progression occur commonly in patients waiting for PCI. Despite the presence of severe coronary lesions, myocardial infarction was rare and no patients died while on the waiting list. Resolution of anginal symptoms was also comparatively common. The pathophysiology of disease progression frequently necessitates a change in the treatment of patients waiting for PCI.


Abbreviations: AE, adverse event; MI, myocardial infarction; PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft; UA, unstable angina

Keywords: coronary angioplasty; angina; pathophysiology




This article has been cited by other articles:


Home page
HeartHome page
S Talwar, M Karpha, R Thomas, C Vurwerk, I C Cox, C J Burrell, J G Motwani, T J Gilbert, and G A Haywood
Disease progression and adverse events in patients listed for elective percutaneous coronary intervention
Heart, January 1, 2006; 92(1): 112 - 112.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 The Fellowship of Postgraduate Medicine